三木 文雄 MIKI FUMIO

ID:9000003230458

大阪市立大学医学部第一内科学教室 The first Department of Internal Medicine, Osaka City University Medical School (1984年 CiNii収録論文より)

Search authors sharing the same name

Articles:  1-20 of 31

  • 1 / 2
  • FUNDAMENTAL AND CLINICAL STUDIES ON TA-058

    MIKI FUMIO , TAKAMATSU KENJI , KOHNO MASAKAZU , BEPPU KEIZO

    TA-058について, 臨床分離菌の感受性を測定するとともに, 少数例の呼吸器感染症に投与し, その治療効果を検討した。<BR>臨床分離<I>S. aureus, E. coli, K. pneumoniae, P. mirabilis, P. vulgaris, P. aeruginosa</I>のTA-058に対する感受性分布のビークは, 低接種菌量の場合, …

    CHEMOTHERAPY 32(Supplement2), 353-355, 1984

    J-STAGE 

  • BASIC AND CLINICAL STUDIES ON NETILMICIN

    MIKI FUMIO , KUBO KENJI , KOHNO MASAKAZU , TAKAMATSU KENJI , BEPPU KEIZO

    Netilmicin sulfateについて, 臨床分離菌の感受性をGentamicinと比較するとともに, 内科系感染症に対する治療成績を検討した。<BR>臨床分離<I>Saureus, E. coli, Klebsiella, P.mirabilis, P.vulgaris, P. aemgimsa</I>のNetilmicinに対する感受性のピークは, 低 …

    CHEMOTHERAPY 29(Supplement3), 231-237, 1981

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON CEFOPERAZONE (T-1551)

    MIKI FUMIO , KUBO KENJI , KOHNO MASAKAZU , TAKAMATSU KENJI , BEPPU KEIZO

    β-lactamaseに安定性を示し, <I>P.aeruginosa</I>にも抗菌力を有する新しいセファロスポリン系抗生物質, cefoperazone (CPZ, T-1551) について検討を行ない, 以下の成績を得た。<BR>臨床分離<I>S. aureus, E. coli, Klebsiella, P. mirabilis, P. vu …

    CHEMOTHERAPY 28(Supplement6), 481-488, 1980

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON CEFTIZOXIME

    MIKI FUMIO , TAKAMATSU KENJI , KUBO KENJI , KOHNO MASAKAZU , BEPPU KEIZO

    Ceftizoximeについて基礎的ならびに臨床的検討を行った。<BR>臨床分離の<I>S. aureus, E. coil, Kiobsiolla, P. mirabilie, P. vulgaris, P. aeruenosa, H. influbnzae</I>の本物質に対する感受性分布のピークは, それぞれ1.56, ≦0.1, ≦0.1, ≦0.1, …

    CHEMOTHERAPY 28(Supplement5), 367-379, 1980

    J-STAGE  Ichushi Web 

  • BASIC AND CILNICAL STUDIES ON CEFROXADINE (CGP-9000)

    MIKI FUMIO , KUBO KENJI , KAWAI MICHIHIDE , TAKAMATSU KENJI , KOHNO MASAKAZU

    Cefroxadine (CGP-9000, CXD) について, 臨床分離幽に対する抗菌力を測定し, 併せて, 内科系感染症に対する治療効果を検討した.<BR>低接種菌量により測定した病巣分離の<I>S.aureus, E.coli, Klebsiella, P.mirabilis, P.vulgaris</I>のCXDに対する感受性分布のピークは, 3.12 …

    CHEMOTHERAPY 28(Supplement3), 260-265, 1980

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON CEFOTAXIME

    MIKI FUMIO , KUBO KENJI , KOHNO MASAKAZU , TAKAMATSU KENJI

    Cefotaxime (CTX) について, 基礎的検討を加えるとともに, 内科系感染症に投与し, 治療効果と副作用について検討を行なった。低接種菌量における臨床分離菌のCTXに対する感受性分布のピークは, <I>S. aureus</I>では1.56μg/mlに, <I>E. coli, Klebsiella, P. mirabilis, P. vulgari …

    CHEMOTHERAPY 28(Supplement1), 349-357, 1980

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON CEFACLOR

    MIKI FUMIO , KUBO KENJI , KOHNO MASAKAZU , TAKAMATSU KENJI

    新しい経口セファロスポリン系抗生物質, Cefaclor (CCL) について検討を行ない, 以下の成績を得た。<BR>1) 臨床分離<I>S. aureus, E. colir, Klebsiellrz, P. mirabilis, P. vulgaris</I>のCCLに対する感受性のピークは, 高接種菌量においてはそれぞれ3.12, 25, 1.56, 1 …

    CHEMOTHERAPY 27(Supplement7), 271-281, 1979

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON BACAMPICILLIN

    MIKI FUMIO , ASAI TOMOKAZU , KUBO KENJI , KAWAI MICHIHIDE , TAKAMATSU KENJI , KOHNO MASAKAZU

    Fundamental and clinical studies of bacampicillin were conducted, and the following results were obtained:<BR>1) Bacampicillin was superior to ampicillin and talampicillin in the absorption from …

    CHEMOTHERAPY 27(Supplement4), 132-142, 1979

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES OF CEFUROXIME

    MIKI FUMIO , ASAI TOMOKAZU , KUBO KENJI , KONO MASAKAZU , TAKAMATSU KENJI

    β-lactamase抵抗性を保有する新しいcephalosporin系抗生物質, Cefuroximeについて検討を行ない, 以下の成績を得た。<BR>臨床分離<I>S. aureus, E. coli, Klebsiella, Proteus </I>sp, の低接種菌量で検査したCefuroxime に対する感受性分布のピークは, それぞれ1.56μg/m …

    CHEMOTHERAPY 27(Supplement6), 408-414, 1979

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON CEFAMANDOLE

    MIKI FUMIO , ASAI TOMOKAZU , KUBO KENJI , KOHNO MASAKAZU , TAKAMATSU KENJI

    Cefamandole sodiumについて, 基礎的ならびに臨床的検討を行なった。<BR>臨床分離<I>S. aureus</I>, <I>E. coli, Klebsiella, Proteus</I> sp. の本剤に対する感受性ピークは, 低接種菌量の場合, それぞれ0.39, 1.56, 1.56, 0.78μg/mlに存在し, …

    CHEMOTHERAPY 27(Supplement5), 253-259, 1979

    J-STAGE  Ichushi Web 

  • LABORAORY ANDCLINICAI SUDIES ON CS-1170

    MIKI FUMIO , ASAI TOMOKAZU , KUBO KENJI , KAWAI MICHIHIDE , TERADA TADAYUKI , KONO MASAKAZU , TAKAMATSU KENJI

    Laboraory and clinical sudies have been carried ou on CS-1170, a new cephamycin anibioic developed in our counry, and he following resuls were obained.<BR>1) MICs of CS-1170 to <I>Staphylo …

    CHEMOTHERAPY 26(Supplement5), 292-302, 1978

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON PC-904

    MIKI FUMIO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TADAYUKI , TAKAMATSU KENJI , KOHNO MASAKAZU

    Studies on PC-904, a new broad-spectrum semisynthetic penicillin developed in Japan, were carried out, and the following results were obtained.<BR>1) Peaks of MIC distribution of PC-904 against …

    CHEMOTHERAPY 26(Supplement2), 336-347, 1978

    J-STAGE  Ichushi Web 

  • THE BIOASSAY METHOD OF PC-904 IN BODY FLUIDS

    KOMATSU TOSHIAKI , KISAKI YOKO , IRIE KENJI , EDA YASUKO , OKUDA TAKAO , NOGUCHI HIROSHI , IZAWA AKIO , MIKI FUMIO

    Studies on the bioassay method of PC-904 concentration in body fluids were performed and the following results using <I>Micrococcus luteus</I> ATCC 9341 as an assay organism in heart infus …

    CHEMOTHERAPY 26(Supplement2), 159-167, 1978

    J-STAGE  Ichushi Web 

  • LABORATORY AND CLINICAL STUDIES ON TICARCILLIN

    MIKI FUMIO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TADAYUKI , TAKAMATSU KENJI , KONO MASAKAZU

    Laboratory and clinical studies were performed on ticarcillin, a new semi-synthetic penicillin with broad antibacterial spectrum, and the following results were obtained.<BR>1) As to the distrib …

    CHEMOTHERAPY 25(9), 2624-2631, 1977

    J-STAGE  Ichushi Web 

  • BASIC AND CLINICAL STUDIES ON KW-1062

    MIKI FUMIO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TADAYUKI , TAKAMATSU KENJI , KONO MASAKAZU

    From basic and clinical studies on KW-1062, the following results were obtained.<BR>1) Antibacterial activity of KW-1062 against various clinically isolated organisms, such as <I>Staphyloc …

    CHEMOTHERAPY 25(7), 2017-2023, 1977

    J-STAGE  Ichushi Web 

  • SUMMARY OF BASIC AND CLINICAL STUDIES ON KW-1062 CONDUCTED IN JAPAN

    OHKOSHI MASAAKI , MASHIMO KEIMEI , ISHIGAMI JOJI , MIKI FUMIO

    The physico-chemical properties, antibacterial spectrum, antibacterial activity, distribution of MICs against clinical isolates and <I>in vivo</I> activity of KW-1062 proved to be similar …

    CHEMOTHERAPY 25(7), 1781-1800, 1977

    J-STAGE  Ichushi Web 

  • CLINICAL STUDIES OF EFFICACY COMPARISON BETWEEN CEFTEZOLE AND CEFAZOLIN IN PNEUMONIA

    NAKAGAWA KEIICHI , YAMASAKU FUSANOSUKE , IWANAGA MORITO , WATANABE MAKOTO , SEKINE OSAMU , USUDA YOSHIMARU , UEDA YASUSHI , MATSUMOTO FUMIO , SAITO ATSUSHI , SHIMIZU KIHACHIRO , MASHIMO KEIMEI , KABE JUNZABURO , FUKAYA KAZUFUTO , KUNII OTOHIKO , KITAMOTO OSAMU , KOBAYASHI HIROYUKI , SHIMADA KAORU , KATSU MASATAKA , FUJIMORI IPPEI , SHIMADA SANAKA , GOMI KENICHI , FUKUSHIMA KOKICHI , WATANABE KENTARO , ITO AKIRA , YAMAMOTO TOSHIYUKI , SHIOTA KENZO , MIKI FUMIO , OKUBO HIROSHI , OKAMOTO YURUKO , UBA FUMIHIKO , MAEHARA KEIGO , KAWAMORI YUZO , NISHIZAWA NATSUO , KATO YASUMICHI , TSUJIMOTO TAKEHIRO , YAMAGUCHI SAKIMORI , OYAMA KAORU , SOEZIMA RINZO , KIMURA NAOMI , KURIMURA OSAMU , HARA KOHEI , NASU MASARU , SAITO ATSUSHI , NAKATOMI MASAO , SAITO AKIRA , NAKAYAMA ICHIRO , KIMURA TAKESHI , AMANO KATSUHIKO , GOTO KOOJI

    The present authors have carried out a double blind test on the patients of pneumonia hospitalized in 23 institutions as indicated in Table 1, to compare clinical effects of ceftezole (CTZ) with those …

    CHEMOTHERAPY 24(4), 926-945, 1976

    J-STAGE  Ichushi Web 

  • LABORATORY AND CLINICAL STUDIES ON CEFTEZOLE

    MIKI FUMIO , OSAKI TATSUO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TAKAYUKI

    Ceftezole (CTZ) has been investigated, and the following results were obtained.<BR>1) CTZ was injected intramuscularly at a dose of 500 mg to healthy adults, to investigate its serum concentrati …

    CHEMOTHERAPY 24(4), 891-894, 1976

    J-STAGE  Ichushi Web 

  • FUNDAMENTAL AND CLINICAL STUDIES ON PIPEMIDIC ACID

    MIKI FUMIO , OZAKI TATSUO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TADAYUKI

    Fundamental and clinical studies on pipemidic acid (PPA) were carried out with the following results.<BR>1. Seven of 31 clinical isolates of <I>Staphylococcus aureus</I> were resista …

    CHEMOTHERAPY 23(9), 2846-2853, 1975

    J-STAGE  Ichushi Web 

  • EXPERIMENTAL AND CLINICAL STUDIES ON AMIKACIN (BB-K8)

    MIKI FUMIO , OZAKI TATSUO , ASAI TOMOKAZU , KAWAI MICHIHIDE , KUBO KENJI , TERADA TADAYUKI

    The experimental and clinical studies on amikacin, a new derivative of kanamycin, were made. The results obtained were as follows.<BR>1) The antibacterial activity of amikacin against the clinic …

    CHEMOTHERAPY 23(6), 2111-2116, 1975

    J-STAGE  Ichushi Web 

  • 1 / 2
Page Top